Mylan Decries 'Hopeless Fishing Expedition' In EpiPen MDL
Mylan NV on Wednesday assailed an effort to access more of its CEO's emails in multidistrict litigation over price hikes for emergency allergy treatment EpiPen, calling the bid a "hopeless fishing...To view the full article, register now.
Already a subscriber? Click here to view full article